Chatbot to help women decide about HPV vaccine
Part of Infections clinical trials.
This study tests whether a chatbot can help women feel more confident about the HPV vaccine and reduce hesitancy. It is for women who have not yet received the vaccine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 15 and 45 years old.
- You have not already had the HPV vaccine.
- You have no medical reason that would prevent you from getting the HPV vaccine.
- You can understand and participate in the study activities.
- You are willing to agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests digital messages (like texts or videos) to help parents in Nigeria decide about the HPV vaccine for their daughters. The vaccine protects against certain cancers, and the goal is to see what messages work best.
This study uses a chatbot (a computer program you can chat with) to give female university students information about the HPV vaccine, which helps prevent certain cancers. The goal is to see if the chatbot can improve your awareness of the vaccine, increase your interest in getting it, and help more students actually get vaccinated.
This trial tests a chatbot (a computer program you can chat with) to see if it helps parents learn about the HPV vaccine, feel more positive about it, and actually get their daughters vaccinated. If you join, you'll use the chatbot and answer questions about your thoughts and decisions.
This trial uses an AI chatbot to help educate gynecologic oncology patients about HPV vaccination. It aims to see if the chatbot improves knowledge and vaccination rates.
This study tests a program that helps adolescent girls and their caregivers learn about the HPV vaccine together. It aims to make it easier for families to decide whether to get the vaccine, which protects against certain cancers and other diseases.
This trial tests whether an AI chatbot can encourage women to take part in cervical cancer screening. It targets women who have not had a recent Pap test and who did not respond to an invitation letter, aiming to improve participation.
Hear when a new HPV Vaccine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.